IL10 and neoplasm: In contrast to IL-1β and IL-4, IL-10 overexpression elicits tumor rejection by stimulating cytotoxicity of CD8 (+) T cells by inducing the expression of IFN-γ in CD8 (+) T cells(Oft et al., 2014).